Notes from the 2022 Folate, Vitamin B12, and One-Carbon Metabolism Conference
Open Access
- 28 March 2023
- journal article
- research article
- Published by MDPI AG in Metabolites
- Vol. 13 (4) , 486
Abstract
Here, we present notes from the Folate, Vitamin B12, and One-Carbon Metabolism Conference organized by The Federation of American Societies for Experimental Biology (FASEB), held in Asheville, North Carolina, USA, 14–19 August 2022. We aim to share the most recent findings in the field with members of our scientific community who did not attend the meeting and who are interested in the research that was presented. The research described includes discussions of one-carbon metabolism at the biochemical and physiological levels and studies of the role of folate and B12 in development and in the adult, and from bacteria to mammals. Furthermore, the summarized studies address the role of one-carbon metabolism in disease, including COVID-19, neurodegeneration, and cancer.Keywords
Funding Information
- Charles H. Hood Foundation (135)
- Gabrielle’s Angels Foundation for Cancer Research (135)
- The Smith Family Awards Program for Excellence in Biomedical Research (135)
- Research and Recruitment Funding by BCH (135)
- Landry Cancer Biology Consortium (135)
This publication has 42 references indexed in Scilit:
- Partitioning of One-Carbon Units in Folate and Methionine Metabolism Is Essential for Neural Tube ClosureCell Reports, 2017
- One-carbon metabolism in cancerBritish Journal of Cancer, 2017
- One-Carbon Metabolism in Health and DiseaseCell Metabolism, 2017
- Vitamin B12 in Health and DiseaseNutrients, 2010
- Peripheral neurological involvement as the first manifestation of spina bifida occulta.1997
- S-Adenosylmethionine and methylation.1996
- S‐Adenosylmetliionine and methylationThe FASEB Journal, 1996
- Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group.1991
- Prevention of neural tube defects: Results of the Medical Research Council Vitamin StudyThe Lancet, 1991
- Temporary Remissions in Acute Leukemia in Children Produced by Folic Acid Antagonist, 4-Aminopteroyl-Glutamic Acid (Aminopterin)New England Journal of Medicine, 1948